Dharamvir Jain
Hematology & Oncology · Louisville, KYNPI 1417938234
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (36.3%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Genentech, Inc. at 50.5% of the total. Reporting peaked in 2022 at $2,287 and has fallen 90.9% since, to $207 in 2024. That places this record below the midpoint for hematology & oncology clinicians in KY, where the typical reported total is $4,619.
Across 21 payments — averaging $162.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$2K
- Daiichi Sankyo Inc.$576
- Covis Pharma GmbH$400
- Gilead$246
- Astrazeneca UK Limited$135
- Bayer$125
- plus $202 from 8 others
Across 11 payments — averaging $54,144 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Daiichi Sankyo Inc.$474K
- AstraZeneca$114K
- Astrazeneca UK Limited$7K
What the payments were for
- Consulting fees$40012%
- Speaking & faculty fees$55016%
- Travel & lodging$1,23536%
- Food & beverage$1,16734%
- Education$491%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 4 | $1,718 |
| Daiichi Sankyo Inc. | 2 | $576 |
| Covis Pharma GmbH | 2 | $400 |
| Gilead | 3 | $246 |
| Astrazeneca UK Limited | 1 | $135 |
| Bayer | 1 | $125 |
| Medtronic | 1 | $82 |
| Pfizer | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Novartis | 1 | $19 |
| AstraZeneca | 1 | $16 |
| Amgen | 1 | $16 |
| Tactile Systems Technology Inc | 1 | $13 |
| Karyopharm Therapeutics Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,402 in reported general payments places this provider in the 40th percentile of 143 hematology & oncology providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Letrozole | 88 | $1,793 |
| Tamoxifen Citrate | 31 | $784 |
| Exemestane | 12 | $728 |
| Anastrozole | 21 | $217 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Louisville
- Vivek SharmaLouisville$647K
- Goetz KloeckerLouisville$584K
- Jeffrey HargisLouisville$450K
- Mohamed HegaziLouisville$380K
- Khuda KhanLouisville$359K
- Jaspreet GrewalLouisville$280K
- Laila AgrawalLouisville$95K
- Brian DongLouisville$31K
- Rohit KumarLouisville$31K
- Vikas SinghLouisville$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.